Study of DF6215 in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Phase 1 Completed
62 enrolled 17 charts
Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer
Phase 1 Completed
15 enrolled
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Phase 1 Completed
15 enrolled 16 charts
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Phase 1 Completed
42 enrolled
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Phase 1 Completed
18 enrolled
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Phase 1 Completed
40 enrolled
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
Phase 1 Completed
86 enrolled 17 charts
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Phase 1 Completed
69 enrolled
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
Phase 1 Completed
27 enrolled
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
Phase 1 Completed
6 enrolled
A Trial Evaluating TG4050 in Ovarian Carcinoma.
Phase 1 Completed
64 enrolled 14 charts
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Phase 1 Completed
40 enrolled 17 charts
Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer
Phase 1 Completed
15 enrolled
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
83 enrolled 21 charts
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Phase 1 Completed
31 enrolled
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
Phase 1 Completed
89 enrolled
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
TRAMUNE
Phase 1 Completed
40 enrolled 23 charts
ARC-12
Phase 1 Completed
94 enrolled
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
Phase 1 Completed
136 enrolled
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
Phase 1 Completed
17 enrolled
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
Phase 1 Completed
60 enrolled
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Phase 1 Completed
54 enrolled
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Phase 1 Completed
285 enrolled
CART-meso in Mesothelin Expressing Cancers
Phase 1 Completed
19 enrolled
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
Phase 1 Completed
16 enrolled 14 charts
Doxil/Caelyx BE Study
Phase 1 Completed
36 enrolled
A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
Phase 1 Completed
56 enrolled
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Phase 1 Completed
3 enrolled
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
Phase 1 Completed
26 enrolled
Continued Access to RXDX-105
Phase 1 Completed
3 enrolled
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase 1 Completed
54 enrolled
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase 1 Completed
39 enrolled
CAR T Cells in Mesothelin Expressing Cancers
Phase 1 Completed
65 enrolled 14 charts
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel
Phase 1 Completed
189 enrolled
Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1
Phase 1 Completed
10 enrolled
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
Phase 1 Completed
66 enrolled
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
Phase 1 Completed
269 enrolled
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
Phase 1 Completed
9 enrolled
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
Phase 1 Completed
19 enrolled 21 charts
Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 1 Completed
25 enrolled
DelVIN
Phase 1 Completed
29 enrolled
Phase 1 Dose Escalation of ArtemiCoffee
Phase 1 Completed
13 enrolled
ACTolog
Phase 1 Completed
38 enrolled